Grossman William (CIK 1730229) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-24). Recent activity: Buy ENGN (5,102 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-24 | enGene Therapeutics Inc. (ENGN) | Interim Chief Medical Officer | Buy | 5,102 | $10,051 |
来源：SEC Form 4 申报文件 · 截至 2026-09-24